Cytokine receptor common beta chain alterations in mediastinal lymphomas

纵隔淋巴瘤细胞因子受体常见β链改变

• 批准号: 489197
• 负责人: Steidl Christian
• 金额: $ 76.35万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2028-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489197&lang=en
• 关键词: Biomarkers; Cytokines; Gene Editing; Gene Mutations; Lymphoma; Mouse Model; Pathogenesis; Signaling Pathways; Targeted Therapy; Tumour Microenvironment; Biomarkers; Cytokines; Gene Editing; Gene Mutations; Lymphoma; Mouse Model; Pathogenesis; Signaling Pathways; Targeted Therapy; Tumour Microenvironment

Lymphoma, which represents the 5th most common malignancy, is a type of cancer involving cells of the immune system, called lymphocytes. Lymphomas which specifically develop in the chest cavity ('anterior mediastinum') with bulky tumour masses, collective

淋巴瘤代表最常见的第5个最常见的恶性肿瘤，是一种涉及免疫系统细胞的癌症，称为淋巴细胞。淋巴瘤在胸腔（“前纵隔”）中特别发育，肿瘤肿块，集体